Artivion (AORT) Assets Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Artivion | 1.02 Bn | 961.00 Mn | 75.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.27% |
| Dec 31, 2025 | 5.07% |
| Sep 30, 2025 | 4.91% |
| Jun 30, 2025 | 3.11% |
| Mar 31, 2025 | 0.40% |
| Dec 31, 2024 | -0.17% |
| Sep 30, 2024 | -0.64% |
| Jun 30, 2024 | -0.87% |
| Mar 31, 2024 | -0.46% |
| Dec 31, 2023 | 0.13% |
| Sep 30, 2023 | -0.32% |
| Jun 30, 2023 | 3.91% |
| Mar 31, 2023 | 6.83% |
| Dec 31, 2022 | 7.99% |
| Sep 30, 2022 | 7.82% |
| Jun 30, 2022 | 8.60% |
| Mar 31, 2022 | 10.03% |
| Dec 31, 2021 | 11.57% |
| Sep 30, 2021 | 12.85% |
| Jun 30, 2021 | 12.42% |
| Mar 31, 2021 | 10.87% |
| Dec 31, 2020 | 10.21% |
| Sep 30, 2020 | 33.86% |
| Jun 30, 2020 | 29.10% |
| Mar 31, 2020 | 24.82% |
| Dec 31, 2019 | 24.20% |
| Sep 30, 2019 | 24.26% |
| Jun 30, 2019 | 25.37% |
| Mar 31, 2019 | 25.47% |
| Dec 31, 2018 | 46.62% |
| Sep 30, 2018 | 46.83% |
| Jun 30, 2018 | 47.97% |
| Mar 31, 2018 | 49.88% |
| Dec 31, 2017 | 49.59% |
| Sep 30, 2017 | 23.02% |
| Jun 30, 2017 | 22.84% |
| Mar 31, 2017 | 22.55% |
| Dec 31, 2016 | 21.86% |
| Sep 30, 2016 | 23.70% |
| Jun 30, 2016 | 24.30% |
| Mar 31, 2016 | 24.57% |
| Dec 31, 2015 | 4.86% |
| Sep 30, 2015 | 5.45% |
| Jun 30, 2015 | 4.00% |
| Mar 31, 2015 | 5.41% |
| Dec 31, 2014 | 6.01% |
| Sep 30, 2014 | 5.78% |
| Jun 30, 2014 | 6.91% |
| Dec 31, 2013 | 8.32% |